Neurocrine Biosciences (NBIX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Neurocrine Biosciences (NBIX) over the last 14 years, with Q4 2025 value amounting to -$247.3 million.
- Neurocrine Biosciences' Other Gross PP&E Adjustments rose 2279.11% to -$247.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$247.3 million, marking a year-over-year increase of 2279.11%. This contributed to the annual value of -$247.3 million for FY2025, which is 2279.11% up from last year.
- According to the latest figures from Q4 2025, Neurocrine Biosciences' Other Gross PP&E Adjustments is -$247.3 million, which was up 2279.11% from -$468.9 million recorded in Q3 2025.
- Neurocrine Biosciences' Other Gross PP&E Adjustments' 5-year high stood at -$45.2 million during Q4 2023, with a 5-year trough of -$502.2 million in Q1 2025.
- Its 4-year average for Other Gross PP&E Adjustments is -$227.8 million, with a median of -$247.3 million in 2025.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 60862.83% in 2024, then soared by 2279.11% in 2025.
- Neurocrine Biosciences' Other Gross PP&E Adjustments (Quarter) stood at -$97.9 million in 2021, then skyrocketed by 53.83% to -$45.2 million in 2023, then crashed by 608.63% to -$320.3 million in 2024, then grew by 22.79% to -$247.3 million in 2025.
- Its last three reported values are -$247.3 million in Q4 2025, -$468.9 million for Q3 2025, and -$492.3 million during Q2 2025.